Plus Therapeutics Relocates Principal Executive Offices
Ticker: PSTV · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, address-change
TL;DR
PLUS THERAPEUTICS moved its HQ from Austin to Houston, effective March 27, 2025.
AI Summary
On March 27, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report. The filing indicates a change in the company's principal executive offices from Austin, Texas to Houston, Texas. The new address is 2710 REED ROAD Suite 160, Houston, Texas, 77051.
Why It Matters
This relocation may signal operational changes or a strategic shift for Plus Therapeutics, potentially impacting its business operations and accessibility.
Risk Assessment
Risk Level: low — The filing solely reports a change of address for the company's principal executive offices, which is a routine administrative update.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- Austin, Texas (location) — Former principal executive office location
- Houston, Texas (location) — New principal executive office location
- 2710 REED ROAD Suite 160 (location) — New principal executive office address
- March 27, 2025 (date) — Effective date of the change
FAQ
What is the new principal executive office address for PLUS THERAPEUTICS, INC.?
The new principal executive office address is 2710 REED ROAD Suite 160, Houston, Texas, 77051.
When did this change of address become effective?
The change of address became effective on March 27, 2025.
What was the previous location of the principal executive offices?
The previous location was in Austin, Texas.
Is this filing related to a merger or acquisition?
No, this filing (Form 8-K) specifically reports a change in the company's principal executive offices.
What is the IRS Employer Identification Number (EIN) for PLUS THERAPEUTICS, INC.?
The IRS Employer Identification Number (EIN) for PLUS THERAPEUTICS, INC. is 33-0827593.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).